These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27920237)

  • 1. von Willebrand Disease: A Concise Review and Update for the Practicing Physician.
    Swami A; Kaur V
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):900-910. PubMed ID: 27920237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiology of von Willebrand disease: therapeutic implications.
    Schneppenheim R
    Thromb Res; 2011; 128 Suppl 1():S3-7. PubMed ID: 22221847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand disease mutation spectrum and associated mutation mechanisms.
    de Jong A; Eikenboom J
    Thromb Res; 2017 Nov; 159():65-75. PubMed ID: 28987708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of von Willebrand disease.
    Cox Gill J
    Hematol Oncol Clin North Am; 2004 Dec; 18(6):1277-99, viii. PubMed ID: 15511616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlation in a cohort of Portuguese patients comprising the entire spectrum of VWD types: impact of NGS.
    Fidalgo T; Salvado R; Corrales I; Pinto SC; Borràs N; Oliveira A; Martinho P; Ferreira G; Almeida H; Oliveira C; Marques D; Gonçalves E; Diniz M; Antunes M; Tavares A; Caetano G; Kjöllerström P; Maia R; Sevivas TS; Vidal F; Ribeiro L
    Thromb Haemost; 2016 Jul; 116(1):17-31. PubMed ID: 26988807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical approach to genetic testing for von Willebrand disease.
    Pruthi RK
    Mayo Clin Proc; 2006 May; 81(5):679-91. PubMed ID: 16706266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing for von Willebrand disease: the Canadian experience.
    James P; Lillicrap D
    Semin Thromb Hemost; 2006 Jul; 32(5):546-52. PubMed ID: 16862529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance.
    Castaman G; Tosetto A; Rodeghiero F
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():71-4. PubMed ID: 19630772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand disease and aging: an evolving phenotype.
    Sanders YV; Giezenaar MA; Laros-van Gorkom BA; Meijer K; van der Bom JG; Cnossen MH; Nijziel MR; Ypma PF; Fijnvandraat K; Eikenboom J; Mauser-Bunschoten EP; Leebeek FW;
    J Thromb Haemost; 2014 Jul; 12(7):1066-75. PubMed ID: 24750783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
    Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
    Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand disease: recent advances in pathophysiology and treatment.
    Phillips MD; Santhouse A
    Am J Med Sci; 1998 Aug; 316(2):77-86. PubMed ID: 9704661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes.
    Othman M
    Semin Thromb Hemost; 2007 Nov; 33(8):780-6. PubMed ID: 18175283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of type 1 von Willebrand disease.
    Goodeve A
    Curr Opin Hematol; 2007 Sep; 14(5):444-9. PubMed ID: 17934350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [von Willebrand factor and von Willebrand disease].
    Matsui T; Hamako J
    Rinsho Ketsueki; 2016; 57(10):2113-2123. PubMed ID: 27795521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.
    Franchini M; Mannucci PM
    Expert Rev Hematol; 2016 Sep; 9(9):825-30. PubMed ID: 27427955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic characteristics of blood outgrowth endothelial cells from patients with von Willebrand disease.
    Groeneveld DJ; van Bekkum T; Dirven RJ; Wang JW; Voorberg J; Reitsma PH; Eikenboom J
    J Thromb Haemost; 2015 Oct; 13(10):1854-66. PubMed ID: 26270243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein.
    Schneppenheim R; Budde U
    J Thromb Haemost; 2011 Jul; 9 Suppl 1():209-15. PubMed ID: 21781257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.